K.C. Balaji, M.B.B.S. (M.D.), FRCS, MRCS, LRCP

K.C. Balaji M.B.B.S. (M.D.), FRCS, MRCS, LRCP

Professor & Chair, Department of Urology; Program Director, Advanced Urology Fellowship

Department: Department of Urology
Business Phone: (904) 244-7340

About K.C. Balaji

Dr. Balaji is widely known as a pioneer in the field of robotic surgery. He is highly regarded as an expert in managing advanced urological cancers of the prostate, bladder, kidney, testes and penis.

Board Certifications

  • Urology

Clinical Profile

Specialties
  • Urologic Oncology
  • Urology

Publications

2023
Does care fragmentation in patients with bladder cancer lead to worse outcomes?
Urologic Oncology: Seminars and Original Investigations.41(3):147.e7-147.e14[DOI] 10.1016/j.urolonc.2022.10.028.[PMID] .
2022
3JC48-3 (methyl 4′-methyl-5-(7-nitrobenzo[c][1,2,5]oxadiazol-4-yl)-[1,1′-biphenyl]-3-carboxylate): a novel MYC/MAX dimerization inhibitor reduces prostate cancer growth
Cancer Gene Therapy.29(11):1550-1557[DOI] 10.1038/s41417-022-00455-4.[PMID] .
2022
Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) in suspected muscle invasive bladder cancer: A systematic review and diagnostic meta-analysis.
Urologic oncology.40(2):45-55[DOI] 10.1016/j.urolonc.2021.11.008.[PMID] 34895996.
2022
The Geriatric Nutritional Risk Index Predicts Postoperative Outcomes in Bladder Cancer: A Propensity Score-Matched Analysis.
The Journal of urology.207(4):797-804[DOI] 10.1097/JU.0000000000002342.[PMID] 34854753.
2021
An Indirect Comparison of Newer Minimally Invasive Treatments for Benign Prostatic Hyperplasia: A Network Meta-Analysis Model.
Journal of endourology.35(4):409-416[DOI] 10.1089/end.2020.0739.[PMID] 32962442.
2021
Intracorporeal versus extracorporeal urinary diversion following robot-assisted radical cystectomy: a meta-analysis, cumulative analysis, and systematic review.
Journal of robotic surgery.15(3):321-333[DOI] 10.1007/s11701-020-01174-4.[PMID] 33222043.
2021
MRI and CT bladder segmentation from classical to deep learning based approaches: Current limitations and lessons.
Computers in biology and medicine.134():104472-[DOI] 10.1016/j.compbiomed.2021.104472.[PMID] 34023696.
2021
Pathology grade influences competing mortality risks in elderly men with prostate cancer.
Urologic oncology.39(8):493.e1-493.e7[DOI] 10.1016/j.urolonc.2020.12.004.[PMID] 33353870.
2021
Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: What about the Negatives?
Radiology.298(1):E57-[DOI] 10.1148/radiol.2020202870.[PMID] 33141006.
2020
A Systematic Review and Meta-Analysis of Methods Used to Reduce Infectious Complications Following Transrectal Prostate Biopsy.
Urology.144():21-27[DOI] 10.1016/j.urology.2020.06.005.[PMID] 32569659.
2020
Comparative efficacy of apalutamide darolutamide and enzalutamide for treatment of non-metastatic castrate-resistant prostate cancer: A systematic review and network meta-analysis.
Urologic oncology.38(11):826-834[DOI] 10.1016/j.urolonc.2020.03.022.[PMID] 32605736.
2020
Meta-analysis and systematic review of intermediate-term follow-up of prostatic urethral lift for benign prostatic hyperplasia.
International urology and nephrology.52(6):999-1008[DOI] 10.1007/s11255-020-02408-y.[PMID] 32065331.
2020
Re: Antibiotic Prophylaxis for the Prevention of Infectious Complications following Prostate Biopsy: A Systematic Review and Meta-AnalysisA. Pilatz, K. Dimitropoulos, R. Veeratterapillay, Y. Yuan, M. I. Omar, S. MacLennan, T. Cai, F. Bruyère, R. Bartoletti, B. Köves, F. Wagenlehner, G. Bonkat and B. Pradere J Urol 2020; 204: 224-230.
The Journal of urology.204(6):1349-1350[DOI] 10.1097/JU.0000000000001332.[PMID] 32830995.
2020
Symptomatic Pituitary Metastasis as Initial Manifestation of Renal Cell Carcinoma: Case Report and Review of Literature.
Case reports in endocrinology.2020():8883864-[DOI] 10.1155/2020/8883864.[PMID] 32908722.
2017
Beta-catenin represses protein kinase D1 gene expression by non-canonical pathway through MYC/MAX transcription complex in prostate cancer.
Oncotarget.8(45):78811-78824[DOI] 10.18632/oncotarget.20229.[PMID] 29108267.
2013
Preoperative neutrophil/lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy.
Journal of endourology.27(8):1046-50[DOI] 10.1089/end.2012.0606.[PMID] 23517015.
2010
Robotic partial cystectomy for bladder cancer: a single-institutional pilot study.
Journal of endourology.24(2):223-7[DOI] 10.1089/end.2009.0367.[PMID] 20039797.
2006
Comparative analysis of early perioperative outcomes following radical cystectomy by either the robotic or open method.
JSLS : Journal of the Society of Laparoendoscopic Surgeons.10(2):145-50[DOI] .[PMID] 16882409.
2006
Metallothioneins and resistance to cisplatin and radiation in prostate cancer.
Urology.67(6):1341-7[DOI] .[PMID] 16765200.
2005
Aberrant expression of E-cadherin and beta-catenin in human prostate cancer.
Urologic oncology.23(6):402-6[DOI] .[PMID] 16301117.
2005
Feasibility of robotic radical nephrectomy--initial results of single-institution pilot study.
Urology.65(6):1086-9[DOI] .[PMID] 15913733.
2005
Robotic transperitoneal detrusor myotomy: description of a novel technique.
Journal of endourology.19(4):476-9[DOI] .[PMID] 15910260.
2005
Tissue transglutaminase interacts with protein kinase A anchor protein 13 in prostate cancer.
Urologic oncology.23(6):407-12[DOI] .[PMID] 16301118.
2004
Feasibility of robot-assisted totally intracorporeal laparoscopic ileal conduit urinary diversion: initial results of a single institutional pilot study.
Urology.63(1):51-5[DOI] .[PMID] 14751347.
2004
Microarray analysis of differential gene expression in androgen independent prostate cancer using a metastatic human prostate cancer cell line model.
Urologic oncology.22(4):313-20[DOI] .[PMID] 15283889.
2002
Laparoscopic vasectomy: case report and review of the literature.
Journal of endourology.16(2):105-6[DOI] .[PMID] 11962550.
2000
Concordant prune belly syndrome in monozygotic twins.
Urology.55(6):949-[DOI] .[PMID] 10840120.
1999
Effect of neoadjuvant hormonal therapy on prostatic intraepithelial neoplasia and its prognostic significance.
The Journal of urology.162(3 Pt 1):753-7[DOI] .[PMID] 10458359.
1999
Upper tract recurrences following radical cystectomy: an analysis of prognostic factors, recurrence pattern and stage at presentation.
The Journal of urology.162(5):1603-6[DOI] .[PMID] 10524877.
1997
Antiproliferative effects of c-myc antisense oligonucleotide in prostate cancer cells: a novel therapy in prostate cancer.
Urology.50(6):1007-15[DOI] .[PMID] 9426742.
1995
Laparoscopic diagnosis and management of transverse testicular ectopia.
Urology.46(6):879-80[DOI] .[PMID] 7502436.

Office Information

Academic Office
2nd Floor, Faculty Clinic
653 West 8th Street, FC12
Jacksonville, FL 32209
(904) 244-7340
Kethandapatti.Balaji@jax.ufl.edu
Senior Medical Secretary
Melanie Prescott
(904) 244-7340
Melanie.Prescott@jax.ufl.edu
GME Office
2nd Floor, Faculty Clinic
653 West 8th Street, FC12
Jacksonville, FL 32209
Phone: (904) 244-7281
Fax: (904) 244-7422
Kethandapatti.Balaji@jax.ufl.edu
Program Coordinator
Shahriar Koochekpour
(904) 244-7281
Shahriar.koochekpour@jax.ufl.edu

Education

Medical Degree
1986 · Madras Medical College, Park Town, India
Urology Residency
1997 · University of Massachusetts Medical Center, Worcester, MA, USA
Urologic Oncology Fellowship
1999 · Memorial Sloan-Kettering Cancer Center, New York, NY, USA